Bioline Rx (BLRX) Financial Statements

3 Followers

Bioline Rx Financial Overview

Bioline Rx's market cap is currently ₪41.94M. The company's EPS TTM is -0.0036; its P/E ratio is -1.64; Bioline Rx is scheduled to report earnings on May 27, 2026, and the estimated EPS forecast is 0.00. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Mar 25	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 1.28M	$ 28.94M	$ 4.80M	$ 0.00	$ 0.00
Gross Profit	$ 462.21K	$ 19.68M	$ 1.11M	$ 0.00	$ 0.00
Operating Income	$ -11.14M	$ -20.41M	$ -49.69M	$ -29.16M	$ -24.78M
EBITDA	$ -10.57M	$ 3.92M	$ -57.09M	$ -28.50M	$ -24.07M
Net Income	$ -1.27M	$ -9.22M	$ -60.61M	$ -20.75M	$ -28.14M
Balance Sheet
Cash & Short-Term Investments	$ 20.88M	$ 19.56M	$ 42.99M	$ 51.08M	$ 57.13M
Total Assets	$ 40.91M	$ 38.91M	$ 63.92M	$ 76.38M	$ 81.39M
Total Debt	$ 10.15M	$ 15.04M	$ 11.59M	$ 12.32M	$ 4.65M
Net Debt	$ 6.90M	$ 4.60M	$ 7.34M	$ 1.74M	$ -8.34M
Total Liabilities	$ 17.56M	$ 25.45M	$ 50.70M	$ 25.54M	$ 13.30M
Stockholders' Equity	$ 18.20M	$ 13.46M	$ 13.22M	$ 50.84M	$ 68.09M
Cash Flow
Free Cash Flow	$ -8.77M	$ -43.93M	$ -22.91M	$ -26.56M	$ -23.67M
Operating Cash Flow	$ -8.74M	$ -43.87M	$ -22.61M	$ -26.24M	$ -23.57M
Investing Cash Flow	$ -9.25M	$ 29.37M	$ 1.44M	$ 4.01M	$ -38.22M
Financing Cash Flow	$ 9.62M	$ 20.66M	$ 15.06M	$ 20.44M	$ 57.75M

Currency in USD

Bioline Rx Earnings and Revenue History

Income Statement >

Bioline Rx Debt to Assets

Balance Sheet >

Bioline Rx Cash Flow

Cash Flow >

Bioline Rx Forecast EPS vs Actual EPS

Earnings >